AMYRIS INC (AMRS) Forecast, Price Target & Analyst Ratings
NASDAQ:AMRS • US03236M2008
0.05 USD
-0.01 (-21.87%)
At close: Aug 18, 2023
0.052 USD
+0 (+4%)
After Hours: 8/18/2023, 8:19:54 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AMYRIS INC (AMRS).
Forecast Snapshot
Consensus Price Target
$1.74
+ 3,384.93% Upside
Next Earnings Forecast
Release DateNov 6, 2023
PeriodQ2 / 2023
EPS Estimate$0.30
Revenue Estimate282.46M
ChartMill Buy Consensus
72.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$1.74
Upside
+ 3,384.93%
From current price of $0.05 to mean target of $1.74, Based on 14 analyst forecasts
Low
$0.71
Median
$1.15
High
$5.25
Price Target Revisions
1 Month
0.00%
3 Months
-18.97%
Price Target Summary
14 Wall Street analysts provided a forecast for the next 12 months for AMRS. The average price target is 1.74 USD. This implies a price increase of 3384.94% is expected in the next year compared to the current price of 0.05.
The average price target has been revised downward by 18.97% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
72.86%
AMRS was analyzed by 14 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about AMRS.
In the previous month the buy percentage consensus was at a similar level.
AMRS was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-05-18 | Jefferies | Downgrade | Buy -> Hold |
| 2023-04-28 | Canaccord Genuity | Initiate | Buy |
| 2023-04-26 | Piper Sandler | Maintains | Neutral |
| 2022-11-10 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-11-09 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-09-19 | Piper Sandler | Maintains | Neutral |
| 2022-08-10 | Roth Capital | Downgrade | Buy -> Neutral |
| 2022-06-24 | JP Morgan | Initiate | Neutral |
| 2022-05-25 | Piper Sandler | Initiate | Neutral |
| 2021-08-06 | Oppenheimer | Maintains | Outperform |
| 2021-08-06 | Roth Capital | Maintains | Buy |
| 2021-08-06 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-01 | HSBC | Initiate | Buy |
| 2021-03-03 | H.C. Wainwright | Maintains | Buy |
| 2021-03-03 | Roth Capital | Maintains | Buy |
| 2021-02-26 | Roth Capital | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateNov 6, 2023
PeriodQ2 / 2023
EPS Estimate$0.30
Revenue Estimate282.46M
Revenue Q2Q333.17%
EPS Q2Q189.57%
Number of Analysts9
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
AMRS is expected to report earnings on 11/6/2023. The consensus EPS estimate for the next earnings is 0.3 USD and the consensus revenue estimate is 282.46M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 173.1M 13.43% | 341.817M 97.47% | 269.847M -21.06% | 536.86M 98.95% | 494.19M -7.95% | 619.74M 25.41% | 645.07M 4.09% | 792.04M 22.78% | 966.28M 22.00% | 1.171B 21.19% | 1.409B 20.32% | |
| EBITDA YoY % growth | -113.93M 2.56% | -155.696M -36.66% | -575.848M -269.85% | -142.093M 75.32% | -180.628M -27.12% | -56.141M 68.92% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -123.3M -1.48% | -165.422M -34.16% | -592.665M -258.27% | -192.211M 67.57% | -159.131M 17.21% | -77.515M 51.29% | -194.647M -151.11% | -67.476M 65.33% | 35.006M 151.88% | 147.1M 320.21% | 283.37M 92.64% | |
| Operating Margin | -71.23% | -48.39% | -219.63% | -35.80% | -32.20% | -12.51% | -30.17% | -8.52% | 3.62% | 12.56% | 20.11% | |
| EPS YoY % growth | -1.79 25.64% | -0.98 45.25% | -1.68 -71.43% | -0.55 67.21% | -0.49 11.11% | -0.26 47.62% | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.30 189.57% | -0.25 50.75% | -0.21 57.74% | -0.15 53.64% | -0.10 -133.49% | -0.08 66.86% | -0.02 90.34% |
| Revenue Q2Q % growth | 282.46M 333.17% | 87.718M 23.32% | 105.31M 38.93% | 92.769M 65.41% | 121.53M -56.97% | 133.37M 52.04% | 151.98M 44.32% |
| EBITDA Q2Q % growth | 111.16M 181.52% | -78.412M 42.66% | -67.488M 57.74% | -44.268M 60.40% | -30.192M -127.16% | -19.176M 75.54% | -5.61M 91.69% |
| EBIT Q2Q % growth | 110.06M 176.74% | -87.215M 41.14% | -73.983M 58.08% | -60.486M 48.58% | -44.268M -140.22% | -33.966M 61.05% | -19.686M 73.39% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
22.70%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
26.80%
Revenue Next 5 Year
21.11%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
23.52%
EBIT Next 5 Year
N/A
AMYRIS INC / AMRS Forecast FAQ
What is the price target for AMRS stock?
14 analysts have analysed AMRS and the average price target is 1.74 USD. This implies a price increase of 3384.94% is expected in the next year compared to the current price of 0.05.
When does AMYRIS INC (AMRS) report earnings?
AMYRIS INC (AMRS) will report earnings on 2023-11-06, after the market close.
What are the consensus estimates for AMYRIS INC (AMRS) next earnings?
The consensus EPS estimate for the next earnings of AMYRIS INC (AMRS) is 0.3 USD and the consensus revenue estimate is 282.46M USD.
What is the expected long term growth rate for AMYRIS INC (AMRS)?
The expected long term growth rate for AMYRIS INC (AMRS) is 26.8%.